Results 21 to 30 of about 8,118,448 (212)

Portal Vein Embolization for Hepatocellular Carcinoma [PDF]

Liver Cancer, 2012
Portal vein embolization (PVE) improves the safety of major hepatectomy through hypertrophy of the future liver remnant (FLR), atrophy of the liver volume to be resected, and improvement in patient selection. Because most patients with hepatocellular carcinoma (HCC) have liver parenchymal injury due to underlying viral hepatitis or alcoholic liver ...
Junichi, Shindoh, Ching-Wei, D Tzeng, Jean-Nicolas, Vauthey   +2 more
openaire   +2 more sources

Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review

World Journal of Surgical Oncology, 2021
Background Transcatheter arterial chemoembolization has been widely used in patients with hepatocellular carcinoma. However, double blood supply and the existence of portal vein tumor thrombus influence the efficacy of transcatheter arterial ...
Zhiying Shao, Xin Liu, Chanjuan Peng, Liping Wang, Dong Xu   +4 more
doaj   +1 more source

Quality Improvement for Portal Vein Embolization [PDF]

CardioVascular and Interventional Radiology, 2010
Future liver remnant (FLR) is the liver that will be left in place after surgery and that was not targeted by embolization. The FLR must hypertrophy after portal vein embolization (PVE). Most teams wait 4 weeks before surgery. FLR hypertrophy must be measured by way of computed axial tomography (CAT) examination after injection of iodine with ...
Denys A, Bize P, Demartines N, Deschamps F, De Baere T   +4 more
openaire   +3 more sources

Correlation between intrahepatic iodine quantity after portal vein embolization and future liver remnant hypertrophy. [PDF]

Jpn J Radiol
PURPOSE: This study investigated the correlation between future liver remnant (FLR) hypertrophy and iodine content in the FLR following portal vein embolization, as measured by dual-energy computed tomography (DECT) with direct injection of the contrast ...
Komada T, Sato Y, Matsushima M, Uemura T, Tamashiro D, Asai R, Ito K, Mizuno T, Mizuno T, Ebata T, Naganawa S.   +10 more
europepmc   +2 more sources

Uneven acute non-alcoholic fatty change of the liver after percutaneous transhepatic portal vein embolization in a patient with hilar cholangiocarcinoma – a case report

BMC Gastroenterology, 2017
Background Portal vein embolization is essential for patients with biliary cancer who undergo extended hepatectomy to induce hypertrophy of the future remnant liver.
Chun-Yi Tsai, Motoi Nojiri, Yukihiro Yokoyama, Tomoki Ebata, Takashi Mizuno, Masato Nagino   +5 more
doaj   +1 more source

Splenic vein stenting for recurrent chylous ascites in sinistral portal hypertension: a case report

CVIR Endovascular, 2021
Background Sinistral portal hypertension results from obstruction or stenosis of the splenic vein and is characterized by normal portal vein pressures and liver function tests.
Brian Covello, Jacob Miller, Roberto Fourzali   +2 more
doaj   +1 more source

Controversies of preoperative portal vein embolization [PDF]

Hepatic Oncology, 2016
Portal vein embolization (PVE) is a safe, percutaneous procedure that has been proven to lower the complication rates of curative intent large-volume hepatic resection by inducing hypertrophy of the future liver remnant. While the safety and efficacy of PVE has been well substantiated, there remains controversy with regards to the technical details ...
Benjamin J, May, David C, Madoff
openaire   +2 more sources

Coil volume embolization ratio for preventing recanalization after portal vein embolization [PDF]

, 2021
PURPOSEThe purpose of this study was to evaluate the optimum volume embolization ratio (VER) for the prevention of recanalization after portal vein embolization (PVE) and the influence of recanalization on future liver remnant (FLR) function using ...
Yoshitsugu Tajima, Mitsunari Maruyama, MARUYAMA, Mitsunari, Kitagaki, Hajime, Megumi Nakamura, Hajime Kitagaki, ANDO, Shinji, Takeshi Yoshizako, Shinji Ando, Yoshizako, Takeshi, Nakamura, Megumi, Tajima, Shinji   +11 more
core   +1 more source

Unique case of pelvic congestion syndrome caused by a new communication branch of the portal-vena cava system

Journal of Cardiothoracic Surgery, 2023
Congenital portosystemic shunt (CPS) is a developmental anomaly of the portal vein system. The disease can cause blood from the portal vein to flow into the vena cava, resulting in various atypical clinical manifestations. Pelvic congestion syndrome (PCS)
Wei Zheng, Chun Sun, Jinming Yang, Yingfeng Wu   +3 more
doaj   +1 more source

Volume and flow modulation strategies to mitigate post-hepatectomy liver failure

Frontiers in Oncology, 2022
IntroductionPost hepatectomy liver failure is the most common cause of death following major hepatic resections with a perioperative mortality rate between 40% to 60%.
Richard Bell, Saleema Begum, Raj Prasad, Kojiro Taura, Bobby V. M. Dasari, Bobby V. M. Dasari   +5 more
doaj   +1 more source